JP2020516603A5 - - Google Patents

Download PDF

Info

Publication number
JP2020516603A5
JP2020516603A5 JP2019554789A JP2019554789A JP2020516603A5 JP 2020516603 A5 JP2020516603 A5 JP 2020516603A5 JP 2019554789 A JP2019554789 A JP 2019554789A JP 2019554789 A JP2019554789 A JP 2019554789A JP 2020516603 A5 JP2020516603 A5 JP 2020516603A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
chain variable
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019554789A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020516603A (ja
JP7315466B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/026058 external-priority patent/WO2018187453A1/en
Publication of JP2020516603A publication Critical patent/JP2020516603A/ja
Publication of JP2020516603A5 publication Critical patent/JP2020516603A5/ja
Priority to JP2023115029A priority Critical patent/JP2023145528A/ja
Application granted granted Critical
Publication of JP7315466B2 publication Critical patent/JP7315466B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019554789A 2017-04-05 2018-04-04 生体試料中において改善した性能を有する、timp2に関するアッセイ Active JP7315466B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023115029A JP2023145528A (ja) 2017-04-05 2023-07-13 生体試料中において改善した性能を有する、timp2に関するアッセイ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762482089P 2017-04-05 2017-04-05
US62/482,089 2017-04-05
PCT/US2018/026058 WO2018187453A1 (en) 2017-04-05 2018-04-04 Assays for timp2 having improved performance in biological samples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023115029A Division JP2023145528A (ja) 2017-04-05 2023-07-13 生体試料中において改善した性能を有する、timp2に関するアッセイ

Publications (3)

Publication Number Publication Date
JP2020516603A JP2020516603A (ja) 2020-06-11
JP2020516603A5 true JP2020516603A5 (cg-RX-API-DMAC7.html) 2021-05-13
JP7315466B2 JP7315466B2 (ja) 2023-07-26

Family

ID=63712349

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019554789A Active JP7315466B2 (ja) 2017-04-05 2018-04-04 生体試料中において改善した性能を有する、timp2に関するアッセイ
JP2023115029A Pending JP2023145528A (ja) 2017-04-05 2023-07-13 生体試料中において改善した性能を有する、timp2に関するアッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023115029A Pending JP2023145528A (ja) 2017-04-05 2023-07-13 生体試料中において改善した性能を有する、timp2に関するアッセイ

Country Status (5)

Country Link
US (2) US11718682B2 (cg-RX-API-DMAC7.html)
EP (1) EP3606554A4 (cg-RX-API-DMAC7.html)
JP (2) JP7315466B2 (cg-RX-API-DMAC7.html)
CN (1) CN110709103B (cg-RX-API-DMAC7.html)
WO (1) WO2018187453A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010048346A1 (en) 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX342967B (es) 2009-12-20 2016-10-19 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
CN110007084B (zh) 2013-12-03 2022-11-18 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
WO2016164854A1 (en) 2015-04-09 2016-10-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2017277305A1 (en) 2016-06-06 2018-12-20 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
WO2018187453A1 (en) 2017-04-05 2018-10-11 Astute Medical, Inc. Assays for timp2 having improved performance in biological samples
WO2023225626A2 (en) * 2022-05-20 2023-11-23 Adanate, Inc. Multi-targeting lilrb antibodies and uses thereof

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5698671A (en) 1989-03-21 1997-12-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metalloproteinase peptides
JP3156082B2 (ja) * 1989-03-21 2001-04-16 アメリカ合衆国 マトリックスメタロプロテイナーゼ阻害剤ペプチド
US6797492B2 (en) 1991-05-17 2004-09-28 Merck & Co., Inc. Method for reducing the immunogenicity of antibody variable domains
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
JP3017591B2 (ja) 1992-01-17 2000-03-13 富士薬品工業株式会社 抗ヒトtimp−2モノクローナル抗体の製法およびその利用
US6562596B1 (en) 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6391265B1 (en) 1996-08-26 2002-05-21 Biosite Diagnostics, Inc. Devices incorporating filters for filtering fluid samples
EP1972194A1 (en) 1996-12-03 2008-09-24 Amgen Fremont Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US6045899A (en) 1996-12-12 2000-04-04 Usf Filtration & Separations Group, Inc. Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters
DE69837544T2 (de) 1997-07-16 2007-12-20 Charm Sciences, Inc., Lawrence Testgerät und methode zur entdeckung von analyten in proben
JP2002507725A (ja) 1998-03-16 2002-03-12 クイデル コーポレイション イムノアッセイデバイスおよび方法
US7214542B2 (en) 2003-01-30 2007-05-08 Michael Hutchinson Method of processing assay test results
WO2004096832A2 (en) 2003-04-29 2004-11-11 Children's Medical Center Corporation Novel antiangiogenic peptides
US20070031286A1 (en) 2003-08-11 2007-02-08 Kyowa Medex Co., Ltd. Tool for measuring object to be measured, measuring device, and measuring method
EP1774338B1 (en) 2004-07-28 2009-06-03 F.Hoffmann-La Roche Ag Timp-2 as target/marker of beta cell failure
US7485468B2 (en) 2004-10-15 2009-02-03 Galapagos Bv Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
WO2007048100A2 (en) 2005-10-18 2007-04-26 The Government Of The United States, As Represented By The Secretary Of Health & Human Services Angio-inhibitory peptides derived from human timp-2
WO2010048346A1 (en) 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8900881B2 (en) 2008-12-30 2014-12-02 Jin Po Lee Quantitative analyte assay device and method
EP3150635A3 (en) 2009-10-16 2017-06-21 Omeros Corporation Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation
MX342967B (es) 2009-12-20 2016-10-19 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
CN102791885B (zh) 2010-02-05 2015-09-09 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
WO2011125877A1 (ja) 2010-03-31 2011-10-13 積水メディカル株式会社 イムノクロマトグラフィーを利用した測定方法、イムノクロマトグラフィー用テストストリップ及びイムノクロマトグラフィー用測定試薬キット
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2810825A1 (en) 2010-09-30 2012-04-05 Yoshiro Niitsu Modulation of timp1 and timp2 expression
CA2846602A1 (en) 2011-08-26 2013-03-28 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
WO2013158274A1 (en) 2012-04-20 2013-10-24 Academia Sinica ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
WO2014031476A1 (en) 2012-08-21 2014-02-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mesothelin domain-specific monoclonal antibodies and use thereof
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
WO2014197729A1 (en) 2013-06-05 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
KR20160039682A (ko) * 2013-08-07 2016-04-11 아스튜트 메디컬 인코포레이티드 생물학적 샘플에서 개선된 성능을 가지는 timp2에 대한 검정
AU2014346695B2 (en) 2013-11-06 2020-10-15 Astute Medical, Inc. Assays for IGFBP7 having improved performance in biological samples
CN110007084B (zh) 2013-12-03 2022-11-18 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
KR101605421B1 (ko) 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
GB201505314D0 (en) 2015-03-27 2015-05-13 Victrex Mfg Ltd Polymeric materials
WO2016164854A1 (en) 2015-04-09 2016-10-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2017277305A1 (en) 2016-06-06 2018-12-20 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
EP3532101B1 (en) 2016-10-28 2021-12-08 Astute Medical, Inc. Use of antibodies to timp-2 for the improvement of renal function
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
WO2018187453A1 (en) 2017-04-05 2018-10-11 Astute Medical, Inc. Assays for timp2 having improved performance in biological samples
WO2018208684A1 (en) 2017-05-07 2018-11-15 Astute Medical, Inc. Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy

Similar Documents

Publication Publication Date Title
JP2016505634A5 (cg-RX-API-DMAC7.html)
JP2020530285A5 (cg-RX-API-DMAC7.html)
JP2020500508A5 (cg-RX-API-DMAC7.html)
NZ716369A (en) Anti-ox40 antibodies and methods of using the same
JP2020534830A5 (cg-RX-API-DMAC7.html)
RU2620563C2 (ru) Способ детекции партнера по связыванию мультиспецифического связывающего агента
JP2018042573A5 (cg-RX-API-DMAC7.html)
JP2015531768A5 (cg-RX-API-DMAC7.html)
EA201100527A1 (ru) Биологические продукты
JP2013506428A5 (cg-RX-API-DMAC7.html)
JP2015527365A5 (cg-RX-API-DMAC7.html)
JP2016519932A5 (cg-RX-API-DMAC7.html)
NZ701444A (en) Antibodies to matrix metalloproteinase 9
RU2011148918A (ru) Иммуноглобулин с двумя вариабельными доменами и его применение
JP2015527368A5 (cg-RX-API-DMAC7.html)
JP2015533788A5 (cg-RX-API-DMAC7.html)
EP2295465A3 (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
CN102159591A (zh) 单克隆抗体和使用所述单克隆抗体的免疫测定法
JP2015529202A5 (cg-RX-API-DMAC7.html)
JP2016528236A5 (cg-RX-API-DMAC7.html)
JP2018507254A5 (cg-RX-API-DMAC7.html)
JP2020189843A5 (cg-RX-API-DMAC7.html)
JP2019504013A5 (cg-RX-API-DMAC7.html)
JP2019504014A5 (cg-RX-API-DMAC7.html)
JP2018527895A5 (cg-RX-API-DMAC7.html)